Transient but transformative: Sanofi’s mRNA CAR-T enters in vivo race
Sanofi’s agent uses mRNA that produces transient CAR-T cells, allowing repeated dosing.
Therapy Area
UK health authorities join forces to champion foreign infectious disease trials
Multiple Myeloma Awareness Month: the current and future landscape
Targeted therapies to join chemo as oncology treatment backbone
RFK Jr faces legal challenge from 15 US states over childhood vaccine recommendations
WHO wants improved universal vaccines to win global influenza battle
Theranostics earmarked as “the future” of radiopharmaceuticals
Significant opportunities exist in the global pain market for novel mechanisms and modalities
